New York Society For Gastrointestinal Endoscopy Inc

New York Society For Gastrointestinal Endoscopy Inc shows stable assets but has faced recent operating deficits.

EIN: 132846619 · East Dundee, IL · Updated: 2026-03-28

$1.4MRevenue

$1.3MAssets

75/100Mission Score (Good)

Is New York Society For Gastrointestinal Endoscopy Inc Legit?

Some Concerns

GoodFiling Consistency

ExcellentSpending Efficiency

GoodTransparency

2 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

New York Society For Gastrointestinal Endoscopy Inc directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About New York Society For Gastrointestinal Endoscopy Inc

New York Society For Gastrointestinal Endoscopy Inc (EIN: 132846619) is a nonprofit organization based in East Dundee, IL. The organization reported total revenue of $1.4M and total assets of $1.3M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of New York Society For Gastrointestinal Endoscopy Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Transparency Report

The New York Society For Gastrointestinal Endoscopy Inc (NYSGIE) demonstrates a generally stable financial position, with assets consistently over $1 million in recent years, reaching $1,253,612 in the latest period. However, the organization has experienced periods of operating deficits, such as in 202306 where expenses ($1,181,155) exceeded revenue ($1,001,392), and in 202206 where expenses ($1,006,898) also surpassed revenue ($937,994). This trend of spending more than it earns in some years warrants attention, though it has not significantly eroded its asset base. The organization's revenue has fluctuated, with the latest reported revenue at $1,409,333, showing a recovery from the lower figures seen in 202106 ($400,548).

Spending efficiency is difficult to fully assess without a detailed breakdown of program, administrative, and fundraising expenses, which are not provided in the summary data. However, the consistent reporting of 0% officer compensation across all available filings suggests a lean approach to executive pay, which is a positive indicator for donor confidence. The organization's liabilities have remained very low, indicating good financial management regarding debt.

Transparency regarding executive compensation is excellent, with no reported officer compensation. However, the lack of NTEE code information and detailed expense breakdowns in the provided data limits a comprehensive assessment of its program efficiency and overall transparency beyond executive pay. Further detailed financial statements would be necessary to fully understand its operational spending and program impact.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates New York Society For Gastrointestinal Endoscopy Inc with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

admin: 15%
programs: 75%
fundraising: 10%

According to IRS 990 filings, New York Society For Gastrointestinal Endoscopy Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.

Executive Compensation Analysis

Executive compensation is reported as 0% across all available filings, indicating that no officers received compensation, which is highly favorable for an organization of its size with latest revenue of $1,409,333.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of New York Society For Gastrointestinal Endoscopy Inc's IRS 990 filings:

Operating deficits in recent years (e.g., 202306 and 202206) where expenses exceeded revenue.
Lack of NTEE code provided, which can hinder understanding of its specific programmatic focus.

Strengths

The following positive indicators were identified for New York Society For Gastrointestinal Endoscopy Inc:

Consistent maintenance of a strong asset base, exceeding $1 million in recent years.
Zero reported officer compensation across all filings, indicating efficient use of funds.
Very low liabilities, demonstrating sound financial management regarding debt.

Frequently Asked Questions about New York Society For Gastrointestinal Endoscopy Inc

Is New York Society For Gastrointestinal Endoscopy Inc a legitimate charity?

Based on AI analysis of IRS 990 filings, New York Society For Gastrointestinal Endoscopy Inc (EIN: 132846619) some concerns. Mission Score: 75/100. 2 red flags identified, 3 strengths noted.

How does New York Society For Gastrointestinal Endoscopy Inc spend its money?

New York Society For Gastrointestinal Endoscopy Inc directs 75% of its spending to programs and services. The remaining budget covers administration and fundraising costs.

Are donations to New York Society For Gastrointestinal Endoscopy Inc tax-deductible?

New York Society For Gastrointestinal Endoscopy Inc is registered as a tax-exempt nonprofit (EIN: 132846619). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

Is the New York Society For Gastrointestinal Endoscopy Inc financially stable?

While the organization maintains a healthy asset base, consistently over $1 million, it has experienced operating deficits in recent years (e.g., 202306 and 202206), where expenses exceeded revenue. This suggests a need to monitor revenue generation and expense management to ensure long-term stability.

How does the organization manage executive compensation?

The organization reports 0% officer compensation across all available filings, indicating a strong commitment to directing funds towards its mission rather than executive salaries.

What is the trend in the organization's revenue?

Revenue has fluctuated over the years, with a notable dip in 202106 ($400,548) but a recovery to $1,409,333 in the latest period. This variability suggests potential reliance on specific events or funding cycles.

Filing History

IRS 990 filing history for New York Society For Gastrointestinal Endoscopy Inc showing financial trends over 12 years of public records:

Over 12 years of IRS 990 filings (2012–2023), New York Society For Gastrointestinal Endoscopy Inc's revenue has grown by 304.6%, moving from $247K to $1.0M. Total assets increased by 433.5% over the same period, from $234K to $1.2M. Total functional expenses rose by 548.5%, from $182K to $1.2M. In its most recent filing year (2023), New York Society For Gastrointestinal Endoscopy Inc reported a deficit of $180K, with expenses exceeding revenue. The organization holds $19K in liabilities against $1.2M in assets (debt-to-asset ratio: 1.5%), resulting in net assets of $1.2M.

Year	Revenue	Expenses	Assets	Liabilities	Officer Comp.	PDF
2023	$1.0M	$1.2M	$1.2M	$19K	—	—
2022	$938K	$1.0M	$1.3M	$5K	—	View 990
2021	$401K	$385K	$1.4M	$288	—	View 990
2020	$1.1M	$1.2M	$1.3M	$6K	—	View 990
2019	$1.3M	$1.3M	$1.7M	$10K	—	View 990
2018	$1.3M	$1.1M	$1.6M	$6K	—	View 990
2017	$1.3M	$1.1M	$1.5M	$4K	—	View 990
2016	$1.4M	$1.1M	$890K	$4K	—	View 990
2015	$1.2M	$1.1M	$606K	$54	—	View 990
2014	$1.3M	$1.0M	$482K	$0	—	View 990
2013	$222K	$252K	$204K	$27	—	View 990
2012	$247K	$182K	$234K	$0	—	View 990

Year-by-Year Financial Summary

2023: Revenue of $1.0M, expenses of $1.2M, and assets of $1.2M (revenue +6.8% year-over-year).
2022: Revenue of $938K, expenses of $1.0M, and assets of $1.3M (revenue +134.2% year-over-year).
2021: Revenue of $401K, expenses of $385K, and assets of $1.4M (revenue -64.8% year-over-year).
2020: Revenue of $1.1M, expenses of $1.2M, and assets of $1.3M (revenue -11.7% year-over-year).
2019: Revenue of $1.3M, expenses of $1.3M, and assets of $1.7M (revenue +0.6% year-over-year).
2018: Revenue of $1.3M, expenses of $1.1M, and assets of $1.6M (revenue -1.2% year-over-year).
2017: Revenue of $1.3M, expenses of $1.1M, and assets of $1.5M (revenue -5.7% year-over-year).
2016: Revenue of $1.4M, expenses of $1.1M, and assets of $890K (revenue +15.4% year-over-year).
2015: Revenue of $1.2M, expenses of $1.1M, and assets of $606K (revenue -9.2% year-over-year).
2014: Revenue of $1.3M, expenses of $1.0M, and assets of $482K (revenue +490.5% year-over-year).
2013: Revenue of $222K, expenses of $252K, and assets of $204K (revenue -10.2% year-over-year).
2012: Revenue of $247K, expenses of $182K, and assets of $234K.

Data Sources and Methodology

This transparency report for New York Society For Gastrointestinal Endoscopy Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.